Literature DB >> 18162530

Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide.

Bruce A Adams1, Sarah L Gray, Emma R Isaac, Antonio C Bianco, Antonio J Vidal-Puig, Nancy M Sherwood.   

Abstract

Disruption of the pituitary adenylate cyclase-activating polypeptide (PACAP) gene in mice has demonstrated a role for this highly conserved neuropeptide in the regulation of metabolism and temperature control. Localization of PACAP neurons within hypothalamic nuclei that regulate appetite suggest PACAP may affect feeding and thus energy balance. We used PACAP-null mice to address this question, examining both food intake and energy expenditure. PACAP-null mice were leaner than wild-type littermates due to decreased adiposity and displayed increased insulin sensitivity. The lean phenotype in the PACAP-null mice was completely eliminated if animals were fed a high-fat diet or housed near thermoneutrality (28 C). Further metabolic analyses of PACAP-null mice housed at 21 C indicated that the reduced body weight could not be explained by decreased food intake, increased metabolic rate, or increased locomotor activity. The thyroid hormone axis of PACAP-null mice was affected, because mRNA levels of hypothalamic TRH and brown adipose tissue type 2 deiodinase were reduced in PACAP-null mice housed at room temperature, and brain deiodinase activity was lower in PACAP-null mice after an acute cold challenge compared with wild-type controls. These results demonstrate that PACAP is not required for the regulation of food intake yet is necessary to maintain normal energy homeostasis, likely playing a role in central cold-sensing mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162530      PMCID: PMC2276722          DOI: 10.1210/en.2007-0515

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  41 in total

Review 1.  Minireview: From anorexia to obesity--the yin and yang of body weight control.

Authors:  Jeffrey M Zigman; Joel K Elmquist
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

2.  An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum.

Authors:  F R Crantz; J E Silva; P R Larsen
Journal:  Endocrinology       Date:  1982-02       Impact factor: 4.736

3.  PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance.

Authors:  F Jamen; K Persson; G Bertrand; N Rodriguez-Henche; R Puech; J Bockaert; B Ahrén; P Brabet
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

4.  Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).

Authors:  A Miyata; L Jiang; R D Dahl; C Kitada; K Kubo; M Fujino; N Minamino; A Arimura
Journal:  Biochem Biophys Res Commun       Date:  1990-07-31       Impact factor: 3.575

5.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells.

Authors:  A Miyata; A Arimura; R R Dahl; N Minamino; A Uehara; L Jiang; M D Culler; D H Coy
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

6.  PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.

Authors:  Masanori Nakata; Daisuke Kohno; Norihito Shintani; Yuriko Nemoto; Hitoshi Hashimoto; Akemichi Baba; Toshihiko Yada
Journal:  Neurosci Lett       Date:  2004-11-11       Impact factor: 3.046

7.  Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide.

Authors:  A Absood; D Chen; Z Y Wang; R Håkanson
Journal:  Regul Pept       Date:  1992-08-13

8.  Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.

Authors:  Tetsuya Tachibana; Ei-Suke Saito; Hirokazu Takahashi; Shin Saito; Shozo Tomonaga; Tim Boswell; Mitsuhiro Furuse
Journal:  Regul Pept       Date:  2004-08-15

9.  The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.

Authors:  Kathleen Freson; Hitoshi Hashimoto; Chantal Thys; Christine Wittevrongel; Sophie Danloy; Yoshiko Morita; Norihito Shintani; Yoshiaki Tomiyama; Jos Vermylen; Marc F Hoylaerts; Akemichi Baba; Chris Van Geet
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

10.  Distribution and localization of pituitary adenylate cyclase-activating polypeptide-specific receptor (PAC1R) in the rostral migratory stream of the infant mouse brain.

Authors:  Ryosuke Matsuno; Hirokazu Ohtaki; Tomoya Nakamachi; Jun Watanabe; Sachiko Yofu; Daisuke Hayashi; Takaaki Takeda; Naoko Nonaka; Mayumi Seki; Masahisa Nakamura; Kazuo Itabashi; Seiji Shioda
Journal:  Regul Pept       Date:  2007-08-25
View more
  18 in total

1.  Stimulation of the hypothalamic ventromedial nuclei by pituitary adenylate cyclase-activating polypeptide induces hypophagia and thermogenesis.

Authors:  Jon M Resch; Joanne P Boisvert; Allison E Hourigan; Christopher R Mueller; Sun Shin Yi; Sujean Choi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

2.  Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway.

Authors:  Haofeng Ji; Yu Zhang; Xiu-da Shen; Feng Gao; Cynthia Y Huang; Catalina Abad; Ronald W Busuttil; James A Waschek; Jerzy W Kupiec-Weglinski
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

Review 3.  Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies.

Authors:  Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2014-12-09       Impact factor: 13.382

4.  Pituitary Adenylate Cyclase-Activating Polypeptide in the Ventromedial Hypothalamus Is Responsible for Food Intake Behavior by Modulating the Expression of Agouti-Related Peptide in Mice.

Authors:  Thanh Trung Nguyen; Yuki Kambe; Takashi Kurihara; Tomoya Nakamachi; Norihito Shintani; Hitoshi Hashimoto; Atsuro Miyata
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

5.  Compensatory recovery of blood glucose levels in KKA(y) mice fed a high-fat diet: insulin-sparing effects of PACAP overexpression in β cells.

Authors:  Yusuke Sakurai; Hiroaki Inoue; Norihito Shintani; Akihiro Arimori; Ken-ichi Hamagami; Atsuko Hayata-Takano; Akemichi Baba; Hitoshi Hashimoto
Journal:  J Mol Neurosci       Date:  2012-04-03       Impact factor: 3.444

Review 6.  PACAP: A regulator of mammalian reproductive function.

Authors:  Stephen J Winters; Joseph P Moore
Journal:  Mol Cell Endocrinol       Date:  2020-06-17       Impact factor: 4.102

7.  Early Neurobehavioral Development of Mice Lacking Endogenous PACAP.

Authors:  Jozsef Farkas; Balazs Sandor; Andrea Tamas; Peter Kiss; Hitoshi Hashimoto; Andras D Nagy; Balazs D Fulop; Tamas Juhasz; Sridharan Manavalan; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2017-02-06       Impact factor: 3.444

8.  Effect of VPAC1 Blockade on Adipose Tissue Formation and Composition in Mouse Models of Nutritionally Induced Obesity.

Authors:  H Roger Lijnen; Kathleen Freson; Marc F Hoylaerts
Journal:  J Obes       Date:  2010-06-30

9.  Characterization of the thermoregulatory response to pituitary adenylate cyclase-activating polypeptide in rodents.

Authors:  Eszter Banki; Eszter Pakai; Balazs Gaszner; Csaba Zsiboras; Andras Czett; Paras Rahul Parkash Bhuddi; Hitoshi Hashimoto; Gabor Toth; Andrea Tamas; Dora Reglodi; Andras Garami
Journal:  J Mol Neurosci       Date:  2014-07-04       Impact factor: 3.444

Review 10.  Pleiotropic pituitary adenylate cyclase-activating polypeptide (PACAP): Novel insights into the role of PACAP in eating and drug intake.

Authors:  Andrew T Gargiulo; Genevieve R Curtis; Jessica R Barson
Journal:  Brain Res       Date:  2019-12-26       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.